Christopher Ton, Ph.D., is a Principal Scientist at Merck, specializing in stem cells, cell therapy, aseptic processing, and large-scale GMP clinical manufacturing. They have held multiple roles at Merck, including Associate Director and Associate Principal Scientist, focusing on vaccine upstream process development. Previously, Christopher worked as a Process Development Scientist at Osiris Therapeutics and a Scientist at Phylonix Pharmaceuticals and Visible Genetics. Christopher earned a Ph.D. in Molecular Biology from the University of Toronto and completed a Research Fellowship in Cardiovascular Genomics at Harvard Medical School.
Location
Norristown, United States
This person is not in any offices